{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:59:20Z","timestamp":1789545560967,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2017.00256","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T04:16:54Z","timestamp":1512101814000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Serum Interleukin-6 and CCL11\/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis"],"prefix":"10.3389","volume":"5","author":[{"given":"Sigrun Ruth","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"B\u00f6ttger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Range","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"L\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henner","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann Joseph","family":"Girschick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Michael","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1586\/1744666X.2013.824670","article-title":"A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis\/chronic recurrent multifocal osteomyelitis and challenges facing the field","volume":"9","author":"Hedrich","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1546-0096-11-47","article-title":"Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)","volume":"11","author":"Hedrich","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.rdc.2013.05.002","article-title":"Autoinflammatory bone diseases","volume":"39","author":"Stern","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"310206","DOI":"10.1155\/2012\/310206","article-title":"Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO)","volume":"2012","author":"Hofmann","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clim.2012.07.012","article-title":"Attenuated TLR4\/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression","volume":"145","author":"Hofmann","year":"2012","journal-title":"Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00296-010-1768-8","article-title":"Pilot study: possible association of IL10 promoter polymorphisms with CRMO","volume":"32","author":"Hamel","year":"2012","journal-title":"Rheumatol Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clim.2011.08.012","article-title":"Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression","volume":"141","author":"Hofmann","year":"2011","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/art.24402","article-title":"Clinical score for nonbacterial osteitis in children and adults","volume":"60","author":"Jansson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ncprheum0653","article-title":"Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated?","volume":"3","author":"Girschick","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00296-016-3466-7","article-title":"Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO)","volume":"36","author":"Hofmann","year":"2016","journal-title":"Rheumatol Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","article-title":"Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release","volume":"161","author":"Hofmann","year":"2015","journal-title":"Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3899\/jrheum.160256","article-title":"Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies","volume":"43","author":"Hofmann","year":"2016","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-0609.1996.tb00495.x","article-title":"Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopenia","volume":"57","author":"Bruserud","year":"1996","journal-title":"Eur J Haematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00393-016-0077-3","article-title":"[Caspase-1 regulates autoinflammation in rheumatic diseases]","volume":"75","author":"Winkler","year":"2016","journal-title":"Z Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00281-015-0494-4","article-title":"Caspase-1: an integral regulator of innate immunity","volume":"37","author":"Winkler","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/B978-0-323-31696-5.00026-7","article-title":"Cytokines","volume-title":"Kelley and Firestein\u2019s Textbook of Rheumatology","author":"McInnes","year":"2017"},{"key":"B17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","article-title":"Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers","volume":"147","author":"Kessel","year":"2013","journal-title":"Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejcb.2011.09.010","article-title":"Interleukin-6 signalling: more than Jaks and STATs","volume":"91","author":"Eulenfeld","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/B978-1-4377-1738-9.00026-8","article-title":"Cytokines","volume-title":"Kelley\u2019s Textbook of Rheumatology","author":"McInnes","year":"2013"},{"key":"B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2015.04.018","article-title":"Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches","volume":"159","author":"Bruck","year":"2015","journal-title":"Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/prca.201600088","article-title":"Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis","volume":"11","author":"Brescia","year":"2017","journal-title":"Proteomics Clin Appl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/rheumatology\/40.5.574","article-title":"Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis","volume":"40","author":"Crawley","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/ar2041","article-title":"Novel IL10 gene family associations with systemic juvenile idiopathic arthritis","volume":"8","author":"Fife","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B24","first-page":"912","article-title":"IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"28","author":"Moller","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00296-002-0191-1","article-title":"Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography","volume":"22","author":"Shahin","year":"2002","journal-title":"Rheumatol Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/rheumatology\/37.5.562","article-title":"Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis","volume":"37","author":"Muller","year":"1998","journal-title":"Br J Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","article-title":"Cell type-specific regulation of IL-10 expression in inflammation and disease","volume":"47","author":"Hedrich","year":"2010","journal-title":"Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","article-title":"Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury","volume":"143","author":"Hofmann","year":"2012","journal-title":"Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1182\/blood-2009-02-204925","article-title":"Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice","volume":"114","author":"Chitu","year":"2009","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1182\/blood-2005-09-3556","article-title":"Mutation of mouse Mayp\/Pstpip2 causes a macrophage autoinflammatory disease","volume":"107","author":"Grosse","year":"2006","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26021","DOI":"10.1038\/srep26021","article-title":"Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients","volume":"6","author":"Chalan","year":"2016","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2381","article-title":"A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients","volume":"10","author":"Syversen","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7754\/Clin.Lab.2013.121231","article-title":"All eotaxins CCL11, CCL24 and CCL26 are increased but to various extents in pulmonary tuberculosis patients","volume":"60","author":"Sharifabadi","year":"2014","journal-title":"Clin Lab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjogren\u2019s syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jbmr.5650080202","article-title":"Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry","volume":"8","author":"Eriksen","year":"1993","journal-title":"J Bone Miner Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3960\/jslrt.54.49","article-title":"The role of tumor-associated macrophages on serum soluble IL-2R levels in B-cell lymphomas","volume":"54","author":"Sakai","year":"2014","journal-title":"J Clin Exp Hematop"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00256\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T04:16:57Z","timestamp":1512101817000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00256\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":38,"alternative-id":["10.3389\/fped.2017.00256"],"URL":"https:\/\/doi.org\/10.3389\/fped.2017.00256","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]},"article-number":"256"}}